Evaluation of Endobronchial Coil System for Emphysema Symptom Relief
This study aims to observe how an Endobronchial Coil System can potentially improve your quality of life if you are living with emphysema.
Device Data
Collected from today forward - ProspectivePathologic Processes
+ Pathological Conditions, Signs and Symptoms
+ Emphysema
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: May 1, 2013
Actual date on which the first participant was enrolled.This study is a multi-center registry, designed to observe and gather information about the experiences of patients with emphysema who are using a specific endobronchial coil system for symptom relief. The focus is on individuals who have already received the CE Mark product, a special certification for medical devices in the European market. The main goal of this study is to understand how effective and safe this system is in real-world use, potentially paving the way for improved care and management of emphysema symptoms. Participants in this study will have their quality of life (QOL) measures recorded over time to evaluate changes. The endobronchial coil system is a treatment that is inserted into the lungs to help reduce symptoms of emphysema. The study aims to understand how this system impacts the daily life and overall well-being of the patients. By monitoring these changes, the study hopes to provide valuable insights into the effectiveness and safety of this treatment approach.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1275 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion and exclusion criteria in the Registry are based on CE Mark approved indication and approved Instructions for Use. Patients enrolled and treated in the Registry study should meet the requirements of the PneumRx Endobronchial Coil System Instructions for Use.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 73 locations
Rigshospitalet Copenhaven
Copenhagen, DenmarkHochtaunus-Kliniken, Klinik für Pneumolog und Onkologie
Bad Homburg, GermanyCharité Campus Mitte
Berlin, Germany